SEVINCIO
| Active Ingredient | Sevelamer Carbonate |
| Strength | 400 mg / 800 mg |
| Dosage Form | Tablet |
| Route of Administration | Oral |
| Pack Details | 1 x 10 Tablets |
Indications:
1. Hyperphosphatemia Sevelamer Carbonate effectively lowers serum phosphorus levels in CKD
patients
2. Decreases the prevalence of Hypercalcemia and benefits vascular calcification in
long-term as compared to Calcium based Phosphate binders
FEVINCIO
| Active Ingredient | Ferric Citrate |
| Strength | 210 mg |
| Dosage Form | Tablet |
| Route of Administration | Oral |
| Pack Details | 10 x 10 Tablets |
Indications:
1. Hyperphosphatemia along with anemia effectively reduces serum phosphorus levels along
with the management of anemia in CKD patients on dialysis
2. Ferric Citrate has been approved for "Iron Deficiency Anaemia" in CKD patients
OURSOL
| Active Ingredient | Sodium Bicarbonate |
| Strength | 1000 mg per 15 ml |
| Dosage Form | Oral Solution |
| Route of Administration | Oral |
| Pack Details | 225 ml Bottle |
Indications: Metabolic acidosis
USP: Faster onset of Therapeutic response, Higher bioavailability, Uniform distribution of
drug, Reduce Pill and Fluid load, Best suited for Pediatric and Geriatric, Sugar free thus
suitable for diabetic patients